Biotech

Categories
LTP Special Column (239) Fintech (24) Blockchain / Digital Asset (8) AI (14) ESG (22) Mergers & Acquisitions / Cross-border Investment (8) Capital Market / Securities (249) General Corporate Affairs (162) Infrastructure Projects / Construction Laws (109) Telecommunications and Media (1) Trade Secret (18) Trademark (46) Patent (35) Copyright (79) Competition Law (80) Biotech (37) Energy (14) Media / Entertainment (57) Employment Law (121) Personal Data Protection (39) Arbitration / Litigation (336) Tax (58) Environmental Protection Law (8) PRC Investment and Legal Compliance (31) Other Areas (233)

January 2024

Overview of Key Biotech and Pharmaceutical Issues in Taiwan for 2023

December 2023

The Prohibition on Physicians Posting Medical Advertisements was declared Unconstitutional by the Taiwan Constitutional Court

August 2023

Streamlined Examination Process for Pharmaceutical Patent Term Extension (Taiwan)

January 2023

Draft Amendments to the Rules of Medical Diagnosis and Treatment by Telecommunications Pre-announced by the MOHW of Taiwan

November 2022

Draft "Restrictions on Investment by Medical Juridical Persons Under Article 35, Paragraph 1 of the Medical Care Act" Pre-announced by the MOHW

September 2022

Sub-laws of the Act for the Development of Biotech and Pharmaceutical Industry Enacted and Promulgated by the MOEA and the MOF of Taiwan

September 2022

Reflection on the Benefit Sharing Mechanism for Providers of Specimens or Biological Data in Regenerative Therapy Research (Taiwan)

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (VI) –The MOEA of Taiwan Pre-announced Draft Sub-law: Regulations Governing Management of Research Personnel’s Concurrent Holding of Jobs and Investments by Contribution of Technology to Start-up Biotech and Pharmaceutical Company

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (V) –The Draft Regulations Announced by the MOEA and MOF of Taiwan: Regulations Governing the Tax Deferral for a Top Executive or Technology Investor in Biotech and Pharmaceutical Companies, Regulations Governing Biotech and Pharmaceutical Companies' Issuance of Stock Options, and Regulations Governing Application of Deferred Taxation of Income Tax in Accordance with the Act for the Development of Biotech and Pharmaceutical Industry

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (IV) –The MOEA of Taiwan Announced the Regulatory Highlights of the Drafts Concerning the Tax Credits for the Income from Investment in Biological or Pharmaceutical Companies by Profit-seeking Enterprises or Individuals
< 1 2 3 4 >

Tag Cloud